Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.7K Sell
865
-42
-5% -$2.28K 0.01% 167
2025
Q4
$44.5K Buy
907
+42
+5% +$1.96K 0.01% 179
2025
Q3
$37.3K Hold
865
0.01% 190
2025
Q2
$33.2K Buy
+865
New +$33.1K 0.01% 206
2020
Q4
Sell
-4,240
Closed -$200K 50
2020
Q3
$200K Buy
4,240
+49
+1% +$2.46K 0.11% 47
2020
Q2
$214K Buy
+4,191
New +$215K 0.13% 45

Other funds holding GSK

Quaker Wealth Management's GSK Position: Q1 2026 in Review

Quaker Wealth Management reduced its GSK (GSK) stake by 4.6% in Q1 2026, selling an estimated $2.28K and leaving 865 shares worth $47.7K. The position accounts for 0.01% of the portfolio, ranked #167.

Quaker Wealth Management first reported a position in GSK in Q2 2020 and has held it in 6 quarters since. The position peaked at $214K in Q2 2020. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Quaker Wealth Management held 865 shares of GSK worth $47.7K as of Q1 2026.
  • Quaker Wealth Management sold 42 GSK shares in Q1 2026, an estimated $2.28K.
  • GSK made up 0.01% of Quaker Wealth Management's portfolio in Q1 2026, its #167 holding.
  • Quaker Wealth Management first reported a position in GSK in Q2 2020 and has held it in 6 quarters since.
  • Quaker Wealth Management's GSK position peaked at $214K in Q2 2020.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Quaker Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.